Off it goes, rich valuation achieved at traded price of $6.20 (vs issue price of $5.68). 11.5 times 2013 EBITDA for Vision Eye would be a stock price of around $1.50!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025